Skip to content

INSM

Insmed Incorporated

Stock

$111.12+2.53 (+2.33%)Close Oct 2, 2026

Income statement

LineLast 12 months2025202420232022202120202019201820172016201520132012201120102009
Revenue$1.1B$606M$364M$305M$245M$188M$164M$136M$9.8M$0$0$0$12M$0$4.4M$6.9M$10M
Cost of revenue$188M$123M$86M$66M$55M$44M$40M$24M$2.4M$0$0——————
Gross profit$949M$483M$278M$240M$190M$144M$125M$112M$7.4M$0$0——————
R&D$861M$771M$598M$571M$398M$273M$181M$132M$145M$110M$123M$74M$44M$30M$29M$4.7M$9.2M
SG&A$894M$701M$461M$345M$266M————————————
Other operating expenses$36M$258M$97M$34M—$247M$209M$216M$169M$79M$51M——————
Operating income−$841M−$1.2B−$878M−$710M−$457M−$375M−$265M−$235M−$307M−$189M−$173M−$117M−$55M−$42M−$62M−$8.1M−$8.7M
Non-operating income−$28M−$25M−$32M−$37M−$23M−$61M−$27M−$18M−$17M−$4.0M−$2.8M−$2.7M−$2.3M$1.1M$2.1M$1.7M$128M
Pretax income−$869M−$1.3B−$910M−$747M−$480M−$436M−$293M−$254M−$324M−$193M−$176M−$120M−$57M−$41M−$60M−$6.4M$119M
Taxes$6.2M$5.0M$3.7M$2.6M$1.4M−$1.8M$1.4M$777K$201K−$272K$98K−$2.0M−$1.2M$0$0$78K$477K
Net income−$875M−$1.3B−$914M−$750M−$482M−$435M−$294M−$254M−$324M−$193M−$176M−$118M−$56M−$41M−$60M−$6.4M$118M
Diluted EPS−$4.10−$6.42−$5.57−$5.34−$3.91−$3.88−$3.01−$3.01−$4.22−$2.89−$2.85−$2.02−$1.60−$1.56−$2.95−$0.49$9.30
Diluted shares—199.0M164.0M140.4M123.0M112.1M97.6M84.6M76.9M66.6M61.9M58.6M35.0M26.5M23.3M13.3M12.7M
Revenue growth—+66.7%+19.2%+24.4%+30.2%+14.6%+20.5%+1,287.6%—————−100.0%−36.2%−33.3%—
Gross margin83.5%79.7%76.4%78.5%77.5%76.6%75.7%82.3%75.4%————————
Operating margin−73.9%−205.6%−241.5%−232.5%−186.4%−199.0%−161.3%−172.4%−3,124.9%———−478.4%—−1,397.3%−116.9%−83.6%
Net margin−76.9%−210.5%−251.2%−245.6%−196.3%−230.6%−178.9%−186.4%−3,297.2%———−487.6%—−1,350.8%−93.0%1,140.9%